Original Research

Published on 28 May 2024

Safety assessment of tranexamic acid: real-world adverse event analysis from the FAERS database

in Drugs Outcomes Research and Policies

Ningsheng Tian
Yuxin Sun
Yingying Liu
Jie Jin
Shuai Chen
Huawei Han
Ying Zhang
Zhiwei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388138

2,446 views
1 citation

Opinion

Published on 24 May 2024

Overlooking the obvious: the importance of communicating safety and risks of opioids-the Israeli context

in Drugs Outcomes Research and Policies

Maram Khazen
Shelly Kamin-Friedman

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356968

512 views
1 citation

Original Research

Published on 23 May 2024

Impact of a DSS-supported medication review on the safety of drug therapy and quality of life in patients with antithrombotic therapy

in Drugs Outcomes Research and Policies

Tanja Elnaz Hassanzadeh
Carina Hohmann
Carsten Culmsee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1194201

1,788 views

Mini Review

Published on 22 May 2024

Improvements in technology and the expanding role of time-driven, activity-based costing to increase value in healthcare provider organizations: a literature review

in Drugs Outcomes Research and Policies

Ana Paula Beck Da Silva Etges
Porter Jones
Harry Liu
Xiaoran Zhang
Derek Haas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1345842

1,305 views

Original Research

Published on 22 May 2024

Is it possible to diagnose therapeutic adherence in mild cognitive impairment and dementia patients in clinical practice?

in Drugs Outcomes Research and Policies

Pilar Barnestein-Fonseca
Gloria Guerrero-Pertiñez
Jose Gúzman-Parra
Esperanza Valera-Moreno
Fermín Mayoral-Cleries

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362168

1,010 views

Original Research

Published on 15 May 2024

Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China

in Drugs Outcomes Research and Policies

Yanhong Liu
Rong Shao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1225076

988 views

Original Research

Published on 15 May 2024

Time trends and regional variations in prices of anticancer medicines in China

in Drugs Outcomes Research and Policies

Jinwei Zhang
Shuchen Hu
Xingyu Liu
Xiaoyong Liu
Jieqiong Zhang
Caijun Yang
Yu Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397784

746 views

Systematic Review

Published on 13 May 2024

Effect of ezetimibe–statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis

in Drugs Outcomes Research and Policies

Yun-Jing Zhang
Min Xu
Ji-Qiang Duan
De-Jin Wang
Shi-Liang Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1343582

1,398 views
1 citation

Original Research

Published on 10 May 2024

Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?

in Drugs Outcomes Research and Policies

Elif Hilal Vural
Tolga Kaskati
İsmail Mert Vural
Mustafa Asım Özalp
Bülent Gümüşel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364341

1,990 views
1 citation

Original Research

Published on 09 May 2024

Variables affecting new drug prices in South Korea’s pricing system

in Drugs Outcomes Research and Policies

Dong Yun Lee
Seong Ha Cho
Da Hye Lee
Su Jeong Kang
Jong Hyuk Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1370915

2,986 views

Review

Published on 06 May 2024

Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy

in Drugs Outcomes Research and Policies

Matteo Bolcato
Claudio Jommi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1375891

2,349 views

Brief Research Report

Published on 02 May 2024

A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients

in Drugs Outcomes Research and Policies

Ludan Zhang
Rui Ge
Deng Pan
Pengjie Yue
Jingwen Zhang
Renjie Bian
Xiaojing Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1265840

1,301 views

Systematic Review

Published on 01 May 2024

The effect of bupivacaine on analgesia and safety in patients undergoing hemorrhoidectomy: a meta-analysis

in Drugs Outcomes Research and Policies

Haixia Lu
Min Cai
Dongxi Zhou
Weiwei Li
Hanzhong Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1331965

1,563 views
1 citation

Editorial

Published on 26 Apr 2024

Editorial: Clinical pharmacist service promotes the improvement of medical quality

in Drugs Outcomes Research and Policies

Hao Li
Wei Luan
Zhi-Chun Gu
Shusen Sun
Jianrong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418181

1,028 views
1 citation

Review

Published on 24 Apr 2024

The application of multi-criteria decision analysis in evaluating the value of drug-oriented intervention: a literature review

in Drugs Outcomes Research and Policies

Pengli Su
Kai Zhi
Huanhuan Xu
Jing Xiao
Jun Liu
Zhong Wang
Qiong Liu
Yanan Yu
Haixia Dang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1245825

1,538 views

Editorial

Published on 18 Apr 2024

Editorial: Novel methods and technologies for the evaluation of drug outcomes and policies

in Drugs Outcomes Research and Policies

Blythe Adamson
Amr Makady
Grammati Sarri
Omneya Mohamed
Zaheer Babar
Dalia M. Dawoud

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1396034

1,139 views

Navigation group

Articles

Safety assessment of tranexamic acid: real-world adverse event analysis from the FAERS database

Overlooking the obvious: the importance of communicating safety and risks of opioids-the Israeli context

Impact of a DSS-supported medication review on the safety of drug therapy and quality of life in patients with antithrombotic therapy

Improvements in technology and the expanding role of time-driven, activity-based costing to increase value in healthcare provider organizations: a literature review

Is it possible to diagnose therapeutic adherence in mild cognitive impairment and dementia patients in clinical practice?

Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China

Time trends and regional variations in prices of anticancer medicines in China

Effect of ezetimibe–statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis

Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?

Variables affecting new drug prices in South Korea’s pricing system

Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy

A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients

The effect of bupivacaine on analgesia and safety in patients undergoing hemorrhoidectomy: a meta-analysis

Editorial: Clinical pharmacist service promotes the improvement of medical quality

The application of multi-criteria decision analysis in evaluating the value of drug-oriented intervention: a literature review

Editorial: Novel methods and technologies for the evaluation of drug outcomes and policies